January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
GRI Bio, Inc.
GRI Bio is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated, with an initial focus on IPF and SLE.